This CPB is revised to state that plasmapheresis is considered experimental and investigational for autoimmune inner ear disease, chronic urticaria, idiopathic myopathy, multiple myeloma, neuropsychiatric disorders associated with PANDAS, recurrent focal segmental glomerulosclerosis after renal transplantation, and Waldenstrom's macroglobulinemia.